Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Million hearts--where population health and clinical practice intersect.

Wright JS, Wall HK, Briss PA, Schooley M.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):589-91. doi: 10.1161/CIRCOUTCOMES.112.966978. No abstract available.

2.

Performance measures in million hearts: 2 partners' perspective.

Drozda JP Jr, Holmes DP Jr.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):587-8. doi: 10.1161/CIRCOUTCOMES.112.967018. No abstract available.

3.

Reducing the cardiovascular disease burden: justified means for getting to the end.

Bikdeli B, Barreto-Filho JA.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):580-6. doi: 10.1161/CIRCOUTCOMES.111.964072. No abstract available.

4.

Comprehensive medical management of peripheral arterial disease.

Gandhi S, Weinberg I, Margey R, Jaff MR.

Prog Cardiovasc Dis. 2011 Jul-Aug;54(1):2-13. doi: 10.1016/j.pcad.2011.02.004. Review.

PMID:
21722781
5.

A clinician's guide to the ABCs of cardiovascular disease prevention: the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease and American College of Cardiology Cardiosource Approach to the Million Hearts Initiative.

Hsu S, Ton VK, Dominique Ashen M, Martin SS, Gluckman TJ, Kohli P, Sisson SD, Blumenthal RS, Blaha MJ.

Clin Cardiol. 2013 Jul;36(7):383-93. doi: 10.1002/clc.22137. Epub 2013 May 13. Review.

6.

A virtuous cycle to improve hypertension outcomes at a national level: linking public health and individualized medicine.

Califf RM.

Hypertension. 2009 Feb;53(2):105-7. doi: 10.1161/HYPERTENSIONAHA.108.121608. Epub 2008 Dec 29. No abstract available.

7.

EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group.

Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):530-40. doi: 10.1097/HJR.0b013e3283383f30.

PMID:
20577089
8.

Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".

Paraskevas KI.

J Vasc Surg. 2008 Sep;48(3):776-7; author reply 777. doi: 10.1016/j.jvs.2008.04.074. No abstract available.

9.

Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.

Blonde L, Dempster J, Gallivan JM, Warren-Boulton E.

J Am Acad Nurse Pract. 2006 Nov;18(11):524-33. Review.

PMID:
17064330
10.

[Overview of cardiovascular risk factors].

De la Figuera von Wichmann M, Llisterri Caro JL.

Med Clin (Barc). 2006 Nov 25;127(20):774-5. Review. Spanish. No abstract available.

PMID:
17198664
11.

Worksite health and wellness programs in India.

Babu AS, Madan K, Veluswamy SK, Mehra R, Maiya AG.

Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):501-7. doi: 10.1016/j.pcad.2013.11.004. Epub 2013 Nov 19. Review.

PMID:
24607014
12.

Why Are Some Population Interventions for Diet and Obesity More Equitable and Effective Than Others? The Role of Individual Agency.

Adams J, Mytton O, White M, Monsivais P.

PLoS Med. 2016 Apr 5;13(4):e1001990. doi: 10.1371/journal.pmed.1001990. eCollection 2016 Apr. Erratum in: PLoS Med. 2016 May;13(5):e1002045.

13.

Nurse-coordinated care in CKD: time for translation into practice?

Smith DH, Thorp ML.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1229-31. doi: 10.2215/CJN.03620411. Epub 2011 May 26. No abstract available.

14.

Worksite health and wellness programs: Canadian achievements & prospects.

Després JP, Alméras N, Gauvin L.

Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):484-92. doi: 10.1016/j.pcad.2013.11.002. Epub 2013 Nov 19. Review.

PMID:
24607012
15.

Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.

Cooney MT, Dudina A, Whincup P, Capewell S, Menotti A, Jousilahti P, Njølstad I, Oganov R, Thomsen T, Tverdal A, Wedel H, Wilhelmsen L, Graham I; SCORE Investigators.

Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):541-9. doi: 10.1097/HJR.0b013e32832b38a1.

PMID:
19773660
16.

(8) Cardiovascular disease and risk management.

American Diabetes Association.

Diabetes Care. 2015 Jan;38 Suppl:S49-57. doi: 10.2337/dc15-S011. No abstract available.

PMID:
25537708
17.

[Health policy interventions: the pathway to public health].

Andersen K, Gudnason V.

Laeknabladid. 2013 Mar;99(3):129-34. Review. Icelandic.

PMID:
23486685
18.

Women and cardiovascular disease.

Winterfeld A, Kent H.

NCSL Legisbrief. 2005 Apr-May;13(19):1-2. No abstract available.

PMID:
15830440
19.

Cardiovascular disease prevention and implications for worksite health promotion programs in Brazil.

Cipriano G Jr, Neves LM, Cipriano GF, Chiappa GR, Borghi-Silva A.

Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):493-500. doi: 10.1016/j.pcad.2013.10.018. Epub 2013 Oct 26. Review.

PMID:
24607013
20.

Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.

Leśniak W, Bała MM, Płaczkiewicz-Jankowska E, Topór-Mądry R, Jankowski M, Sieradzki J, Banasiak W; ARETAEUS2 Study Group.

Cardiol J. 2015;22(2):150-9. doi: 10.5603/CJ.a2014.0067. Epub 2014 Oct 9.

PMID:
25299503

Supplemental Content

Support Center